Uriel Halavee

Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ.

Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA.

Covance Biotechnology Services, Inc. develops pharmaceutical products. The company offers two microbiology laboratories, one for mycoplasma analysis, and a second for molecular biology. It provides services to biomolecules, including recombinant proteins, monoclonal antibodies, vaccines, blood products, and gene therapy products. The company was founded by Richard J. Hawkins, V. Bryan Lawlis, and John A. Scarlett in 1995 and is headquartered in Princeton, NJ.

Part of Thermo Fisher Scientific, Inc., Ethrog Biotechnologies Ltd is an Israeli company that develops products and technologies for electrophoretic separation of macromolecules. The company is based in Ness Ziona, Israel. The company was founded by Shmuel Cabilly. Ethrog Biotechnologies was acquired by Invitrogen Corp. on June 21, 2000 for $14.18 million.

BioCep Ltd. develops cell separation technologies. The firm also manufactures and sells cutting-edge technologies for cell isolation. Its product, SmartSep enables cell recovery with magnetic beads removal process before infusion to the patient. The company was founded by Ofer Klein and Aharon Lamish on July 4, 2006 and is headquartered in Ness Ziona, Israel.

DenTack Implants Ltd. develops, manufactures and sells dental implants. Its products include implants, prosthetic components and surgical tools. The firm’s dental implants provide an implant solution for patients with short bone height as an alternative to surgical bone augmentation treatment. The company was founded by Oz Vachtenberg in 2006 and is headquartered in Kfar Saba, Israel.

Biokine Therapeutics Ltd. Is a clinical-stage biopharmaceutical company, which engages in the research and development of biotechnologies for the treatment of cancer. It conducts a pre-clinical and clinical drug research that targets the tumor microenvironment of cancer cells. The company was founded by Amnon Peled in 2000 and is headquartered in Rehovot, Israel.

Medasense Biometrics Ltd. develops pain monitoring devices. The firm is a medical device company that develops a continuous and non-invasive pain-monitoring device. The company was founded by Galit Zuckerman and Itay Goor-Aryeh in 2008 and is headquartered in Ramat Yishai, Israel.

Bristol-Myers Squibb Holdings Pharma Ltd. engages in the pharmaceutical company. The company is headquartered in San Juan, Puerto Rico.

DiA Imaging Analysis Ltd. operates as an imaging processing software company. It technology is based on a platform of proprietary algorithms that enable automatic detection of the heart’s ventricle walls borders. The firm’s platform enables the evaluation of echo images to be fully automated. The company was founded in 2009 and is headquartered in Be'er Sheva, Israel.

BioGenCell Ltd. is an Israeli company based at Laniado Hospital in Israel that is dedicated to improving the lives of patients suffering from degenerative microvascular diseases. The company is based in Netanya, Israel. The company aims to extend its reach to address a wider range of vascular and other diseases in the future. BioGenCell has been committed to transforming the lives of patients with degenerative diseases through advanced cell therapy treatments since its inception in 2008. The company's groundbreaking tract technology uses a patient's own blood as personalized medicine. BioGenCell's personalized treatments are produced from the patients' own cells, mimicking the body's natural processes. The company was founded by Michael Belkin, Yael Porat, and Eyal Peleg, and Yael Porat has been the CEO since incorporation.

The PhRMA Foundation is an organization that provides awards and support to individuals pursuing higher education. The non-profit company is based in Washington. The organization's 2022 annual report highlights their activities and showcases their 2022 awardees.

Silenseed Ltd. operates as a biopharmaceutical company. Its programs include SiG12D-LODER for pancreatic cancer, and Prostate-LODER, GBM-LODER for brain cancer. The company was founded by Dr. Amotz Shemi and Prof. Eithan Galun on November 30, 2008 and is headquartered in Modi’in, Israel.

Samsung Bioepis Co., Ltd. manufactures biopharmaceutical products. The company was founded on February 28, 2012 and is headquartered in Incheon, South Korea.

Torque Therapeutics, Inc. develops immunotherapies to address cancers focused on the specific modulation of immune cell subsets. The company was founded by Bart Henderson, Ulrik B. Nielsen, Darrell J. Irvine, and Thomas Lars Andresen and is headquartered in Cambridge, MA.

Zeev Milbauer Investment Banking Ltd. is an Israeli company that provides investment banking services. The private company is based in Tel Aviv, Israel. Zeev Milbauer has been the CEO of the company since 2015.

Naia Rare Diseases, Inc. develops pharmaceutical drugs for Short Bowel Syndrome (SBS) and other rare gastrointestinal diseases. The firm offers NB 1001 for adult SBS, NB 1001 for pediatric SBS, and NB 1002, a GLP-2 agonist. The company was founded by H. Daniel Perez and Mark Bagnall in 2014 and is headquartered in Cayman Islands.

Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA.

Next Dimension Ltd. develops retinal imaging systems. Its products are used for diagnosis and monitoring the treatment of vision threatening diseases and to measure the quantity of oxygen in different areas of retina cells. The company was founded in 2006 by Sara Krupsky, David Rosenblatt and Marek Sternheim and is headquartered in Ofakim, Israel.